A U.S. jury found Bayer’s Roundup weedkiller did not cause an Oregon man’s cancer, the German agriculture and pharmaceuticals company said on Saturday, handing the firm its fourth consecutive trial victory over such claims.
https://www.pharmalive.com/wp-content/uploads/2021/12/Blood-thinner-drug-Xarelto-tied-to-higher-rate-of-major-side-effects-study-Reuters-12-21-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-06-18 03:12:182022-06-20 09:02:05Bayer wins fourth Roundup weedkiller case in U.S.
